Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis
- PMID: 17171483
- DOI: 10.1007/s00268-006-0066-9
Interleukin-10 gene transfer: prevention of multiple organ injury in a murine cecal ligation and puncture model of sepsis
Abstract
Introduction: The aim of this study was to determine the effect of immunoregulatory cytokine interleukin-10 (IL-10) gene therapy on multiple organ injury (MOI) induced by a cecal ligation and puncture (CLP) model of sepsis in mice.
Methods: Male Balb/c mice subjected to CLP were treated with either an hIL-10-carrying vector or an empty control vector. We assessed the degree of lung, liver, and kidney tissue destruction biochemically by measuring myeloperoxidase (MPO) and malondialdehyde (MDA) activity. Histologic assessments were based on neutrophil infiltration in lung and liver tissue. IL-10 protein expression was examined immunohistochemically, and ultrastructural changes in the liver were studied by transmission electron microscopy. We analyzed the expression of tumor necrosis factor-alpha (TNFalpha) mRNA by reverse transcription polymerase chain reaction 3, 8, and 24 hours after CLP in all organs.
Results: Organ damage was significantly reduced by hIL-10 gene transfer, which was associated at the tissue level with reduced MPO activity in the liver, lung, and kidney and decreased leukocyte sequestration and MDA formation in the lung. The liver MDA was not significantly higher in the hIL-10 gene therapy group than in the controls and seemed not to be affected by hIL-10 gene transfer. The reduced portal tract neutrophilic infiltration and preserved ultrastructure of the hepatocytes also showed that tissue function was not impaired. The lung and kidney TNFalpha mRNA expression was suppressed markedly in the hIL-10 gene therapy group, but liver TNFalpha mRNA expression varied over time.
Conclusions: These findings showed that IL-10 gene therapy significantly attenuated sepsis-induced MOI.
Similar articles
-
Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils.Int Immunopharmacol. 2016 Jun;35:217-225. doi: 10.1016/j.intimp.2016.03.041. Epub 2016 Apr 16. Int Immunopharmacol. 2016. PMID: 27082997
-
Resveratrol reduces renal and lung injury caused by sepsis in rats.J Surg Res. 2006 Aug;134(2):315-21. doi: 10.1016/j.jss.2005.12.027. Epub 2006 Feb 20. J Surg Res. 2006. PMID: 16488442
-
Relationship between cytokine mRNA expression and organ damage following cecal ligation and puncture.World J Gastroenterol. 2002 Feb;8(1):131-4. doi: 10.3748/wjg.v8.i1.131. World J Gastroenterol. 2002. PMID: 11833088 Free PMC article.
-
Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast.Prostaglandins Leukot Essent Fatty Acids. 2005 Dec;73(6):453-62. doi: 10.1016/j.plefa.2005.07.008. Epub 2005 Sep 12. Prostaglandins Leukot Essent Fatty Acids. 2005. PMID: 16162403
-
Sepsis and obesity: a scoping review of diet-induced obesity murine models.Intensive Care Med Exp. 2024 Feb 23;12(1):15. doi: 10.1186/s40635-024-00603-0. Intensive Care Med Exp. 2024. PMID: 38388878 Free PMC article.
Cited by
-
Gene Therapy for Acute Respiratory Distress Syndrome.Front Physiol. 2022 Jan 17;12:786255. doi: 10.3389/fphys.2021.786255. eCollection 2021. Front Physiol. 2022. PMID: 35111077 Free PMC article. Review.
-
Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period.Eur J Clin Pharmacol. 2011 Aug;67(8):803-13. doi: 10.1007/s00228-011-0993-8. Epub 2011 Feb 26. Eur J Clin Pharmacol. 2011. PMID: 21359536
-
Approaches to the Management of Acute Kidney Injury in Children.Recent Pat Biomark. 2011;1(1):49-59. Recent Pat Biomark. 2011. PMID: 23538877 Free PMC article.
-
Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study.Lab Invest. 2009 May;89(5):549-61. doi: 10.1038/labinvest.2009.8. Epub 2009 Feb 2. Lab Invest. 2009. PMID: 19188912 Free PMC article.
-
Clinical review: gene-based therapies for ALI/ARDS: where are we now?Crit Care. 2011;15(3):224. doi: 10.1186/cc10216. Epub 2011 Jun 20. Crit Care. 2011. PMID: 21699743 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous